European Event-Driven Analyst

Jesus Rodriguez Aguilar

Event-Driven

<ul>
<li>June was broadly directionless. The median tightened modestly, while the mean was essentially unchanged as convergence in Volkswagen and Roche was offset by widening in Danieli, Sixt and Carlsberg.</li>
<li>Liquidity-Driven convergence remained selective. Media for Europe, Roche and Volkswagen tightened further, while structurally constrained spreads such as Handelsbanken and Danieli remained firmly anchored.</li>
<li>Telecom Italia exits the universe following completion of the savings-share conversion, leaving ownership structure and implementation constraints as the primary drivers of European dual-class dispersion.</li>
</ul>


June was broadly directionless. The median tightened modestly, while the mean was essentially unchanged as convergence in Volkswagen and Roche was offset by widening in Danieli, Sixt and Carlsberg.
Liquidity-Driven convergence remained selective. Media for Europe, Roche and Volkswagen tightened further, while structurally constrained spreads such as Handelsbanken and Danieli remained firmly anchored.
Telecom Italia exits the universe following completion of the savings-share conversion, leaving ownership structure and implementation constraints as the primary drivers of European dual-class dispersion.


Liquid Universe of European Ordinary and Preferred Shares: June '26 Report

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

Heightened trade tensions have caused global equities to move from resistance to support in a matter of days. Additional consolidation - i.e., no breakdowns - on the broad global indexes (MSCI ACWI, ACWI ex-US, EAFE, and EM) remains the most likely scenario. At the same time, new cracks are beginning to show and as a result we believe global equities are vulnerable to a breakdown.  Along with a recap of important technical levels across major markets, we flip through several attractive Groups and stocks within Advertising, retail, restaurants, and travel, which offer attractive pullback opportunities.

Heightened trade tensions have caused global equities to move from resistance to support in a matter of days. Additional consolidation - i.e., no breakdowns - on the broad global indexes (MSCI ACWI, ACWI ex-US, EAFE, and EM) remains the most likely scenario. At the same time, new cracks are beginning to show and as a result we believe global equities are vulnerable to a breakdown.  Along with a recap of important technical levels across major markets, we flip through several attractive Groups and stocks within Advertising, retail, restaurants, and travel, which offer attractive pullback opportunities.

Global Equity Strategy: Another Test of Support

<ul>
<li>May saw selective convergence reassert itself across Europe’s dual-class universe, with broad tightening in several structurally wide and liquidity-driven spreads offsetting renewed widening in Carlsberg and Grifols.</li>
<li>Both median and mean tightened, confirming no systemic repricing of voting rights. Dispersion remains driven by liquidity, concentrated ownership, implementation constraints and episodic positioning reversals across Europe’s dual-class universe.</li>
<li>Handelsbanken, Media-for-Europe and Telecom Italia delivered the strongest tightening moves in May, while Carlsberg and Grifols reversed sharply, re-widening after April’s convergence phase.</li>
</ul>


May saw selective convergence reassert itself across Europe’s dual-class universe, with broad tightening in several structurally wide and liquidity-driven spreads offsetting renewed widening in Carlsberg and Grifols.
Both median and mean tightened, confirming no systemic repricing of voting rights. Dispersion remains driven by liquidity, concentrated ownership, implementation constraints and episodic positioning reversals across Europe’s dual-class universe.
Handelsbanken, Media-for-Europe and Telecom Italia delivered the strongest tightening moves in May, while Carlsberg and Grifols reversed sharply, re-widening after April’s convergence phase.


Liquid Universe of European Ordinary and Preferred Shares: May '26 Report

Asia Healthcare Analyst, Pathology Associates Limited

Dion Stéfan Büchner M.D., FCAP

Asia Healthcare Analyst

Pathology Associates Limited

Thematic (Sector/Industry)

AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at 2015-20 CAGR of ~12% to 434,214 in 2020.The current standard of care for newly diagnosed patients is a combination of daunorubicin and cytarabine, commonly known as 7+3. However, durable remissions occur only in a minority of adult patients. Hence r/r AML remains a disease of high unmet need, especially for “elderly” patients. Treatment landscape…

AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at 2015-20 CAGR of ~12% to 434,214 in 2020.The current standard of care for newly diagnosed patients is a combination of daunorubicin and cytarabine, commonly known as 7+3. However, durable remissions occur only in a minority of adult patients. Hence r/r AML remains a disease of high unmet need, especially for “elderly” patients. Treatment landscape…

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

We reviewed data presented at the American Society of Hematology (ASH) conference in San Diego last week with a focus on the evolving treatment landscape for non-Hodgkin's lymphoma (NHL), multiple myeloma (MM), myeloadysplastic syndrome (MDS) and acute myeloid leukemia (AML).Data on several novel programs were presented; we review select companies based on our standard abstract assessment methodology. We use our proprietary ranking methodology (PRM) to rank concerned abstracts on seven criteria…

We reviewed data presented at the American Society of Hematology (ASH) conference in San Diego last week with a focus on the evolving treatment landscape for non-Hodgkin's lymphoma (NHL), multiple myeloma (MM), myeloadysplastic syndrome (MDS) and acute myeloid leukemia (AML).Data on several novel programs were presented; we review select companies based on our standard abstract assessment methodology. We use our proprietary ranking methodology (PRM) to rank concerned abstracts on seven criteria…

American Society of Hematology- (ASH) Annual Conference (2016) Review

Spain

Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Grifols SA (GRF SM)

Liquid Universe of European Ordinary and Preferred Shares: June '26 Report

June brought renewed divergence across European ord/pref pairs. Structural outliers widened, convergence became more selective, and implementation...

Jesus Rodriguez Aguilar

Global Equity Strategy: Another Test of Support

Heightened trade tensions have caused global equities to move from resistance to support in a matter of days. Additional consolidation - i.e., no...

Vermilion Research

Liquid Universe of European Ordinary and Preferred Shares: May '26 Report

European dual-class spreads tightened again in May as liquidity-driven convergence resumed. Handelsbanken, MFE and Telecom Italia led compression,...

Jesus Rodriguez Aguilar

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...

Dion Stéfan Büchner M.D., FCAP

American Society of Hematology- (ASH) Annual Conference (2016) Review

We reviewed data presented at the American Society of Hematology (ASH) conference in San Diego last week with a focus on the evolving treatment...

Dion Stéfan Büchner M.D., FCAP

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)